No abstract available
MeSH terms
-
Blood Coagulation Tests
-
Fibrinolytic Agents / administration & dosage
-
Fibrinolytic Agents / therapeutic use
-
Heparin / administration & dosage
-
Heparin / therapeutic use
-
Humans
-
Multicenter Studies as Topic
-
Plasminogen Activators / administration & dosage
-
Plasminogen Activators / therapeutic use
-
Prospective Studies
-
Pulmonary Embolism / blood
-
Pulmonary Embolism / diagnosis
-
Pulmonary Embolism / diagnostic imaging
-
Pulmonary Embolism / drug therapy*
-
Pulmonary Embolism / mortality
-
Pulmonary Embolism / surgery
-
Randomized Controlled Trials as Topic
-
Registries
-
Risk Factors
-
Streptokinase / administration & dosage
-
Streptokinase / therapeutic use
-
Thrombolytic Therapy*
-
Time Factors
-
Tissue Plasminogen Activator / administration & dosage
-
Tissue Plasminogen Activator / therapeutic use
-
Tomography, Spiral Computed
-
Urokinase-Type Plasminogen Activator / administration & dosage
-
Urokinase-Type Plasminogen Activator / therapeutic use
-
Vena Cava Filters
Substances
-
Fibrinolytic Agents
-
Heparin
-
Streptokinase
-
Plasminogen Activators
-
Tissue Plasminogen Activator
-
Urokinase-Type Plasminogen Activator